Gerardus P. J. van Hout

Gerardus P. J. van Hout

Auto-generated profile, based on publicly available information

Gerardus P. J. van Hout

Experimental Cardiology Laboratory University Medical Center Utrecht Utrecht The Netherlands

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2016 in European Heart Journal
Verified
Journal Article
Open access
PDF file
GHGerardus P.J. van Hout
Gerardus P.J. van Hout
LBLena Bosch
Lena Bosch
GEGuilielmus H.J.M. Ellenbroek
Guilielmus H.J.M. Ellenbroek
JHJudith J. de Haan
Judith J. de Haan
WSWouter van Solinge
Wouter van Solinge
IHImo E. Hoefer
Imo E. Hoefer
Myocardial infarction (MI) triggers an intense inflammatory response that is associated with infarct expansion and is detrimental for cardiac function. Interleukin (IL)-1β and IL-18 are key players in this response and are controlled by the NLRP3-inflammasome. In the current study, we therefore hypothesized that selective inhibition of the NLRP3-inflammasome reduces infarct size and preserves cardiac function in a porcine MI model. Thirty female landrace pigs were subjected to 75 min transluminal balloon occlusion and treated with the NLRP3-inflammasome inhibitor MCC950 (6 or 3 mg/kg) or placebo for 7 days in a randomized, blinded fashion. After 7 days, 3D-echocardiography was performed to assess cardiac function and Evans blue/TTC double staining was executed to assess the area at risk (AAR) and infarct size (IS). The IS/AAR was lower in the 6 mg/kg group (64.6 ± 8.8%, P = 0.004) and 3 mg/kg group (69.7 ± 7.2%, P = 0.038) compared with the control group (77.5 ± 6.3%). MCC950 treatment markedly preserved left ventricular ejection fraction in treated animals (6 mg/kg 47 ± 8%, P = 0.001; 3 mg/kg 45 ± 7%, P = 0.031; control 37 ± 6%). Myocardial neutrophil influx was attenuated in treated compared with non-treated animals (6 mg/kg 132 ± 72 neutrophils/mm2, P = 0.035; 3 mg/kg 207 ± 210 neutrophils/mm2, P = 0.5; control 266 ± 158 neutrophils/mm2). Myocardial IL-1β levels were dose-dependently reduced in treated animals. NLRP3-inflammasome inhibition reduces infarct size and preserves cardiac function in a randomized, blinded translational large animal MI model. Hence, NLRP3-inflammasome inhibition may have therapeutic potential in acute MI patients.

8 December 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
MSMax J. M. Silvis
Max J. M. Silvis
SDSelma E. Kaffka Genaamd Dengler
Selma E. Kaffka Genaamd Dengler
COClémence A. Odille
Clémence A. Odille
Mudit MishraMudit Mishra
Mudit Mishra
NKNiels P. van der Kaaij
Niels P. van der Kaaij
GHGerardus P. J. van Hout
Gerardus P. J. van Hout
In the setting of myocardial infarction (MI), ischemia reperfusion injury (IRI) occurs due to occlusion (ischemia) and subsequent re-establishment of blood flow (reperfusion) of a coronary artery. A similar phenomenon is observed in heart transplantation (HTx) when, after cold storage, the donor heart is connected to the recipient’s circulation. Although reperfusion is essential for the survival of cardiomyocytes, it paradoxically leads to additional myocardial damage in experimental MI and HTx models. Damage (or danger)-associated molecular patterns (DAMPs) are endogenous molecules released after cellular damage or stress such as myocardial IRI. DAMPs activate pattern recognition receptors (PRRs), and set in motion a complex signaling cascade resulting in the release of cytokines and a profound inflammatory reaction. This inflammatory response is thought to function as a double-edged sword. Although it enables removal of cell debris and promotes wound healing, DAMP mediated signalling can also exacerbate the inflammatory state in a disproportional matter, thereby leading to additional tissue damage. Upon MI, this leads to expansion of the infarcted area and deterioration of cardiac function in preclinical models. Eventually this culminates in adverse myocardial remodeling; a process that leads to increased myocardial fibrosis, gradual further loss of cardiomyocytes, left ventricular dilation and heart failure. Upon HTx, DAMPs aggravate ischemic damage, which results in more pronounced reperfusion injury that impacts cardiac function and increases the occurrence of primary graft dysfunction and graft rejection via cytokine release, cardiac edema, enhanced myocardial/endothelial damage and allograft fibrosis. Therapies targeting DAMPs or PRRs have predominantly been investigated in experimental models and are potentially cardioprotective. To date, however, none of these interventions have reached the clinical arena. In this review we summarize the current evidence of involvement of DAMPs and PRRs in the inflammatory response after MI and HTx. Furthermore, we will discuss various current therapeutic approaches targeting this complex interplay and provide possible reasons why clinical translation still fails.

7 September 2015 in Expert Opinion on Therapeutic Targets
Verified
Journal Article
Closed access
GHGerardus P J Van Hout
Gerardus P J Van Hout
FAFatih Arslan
Fatih Arslan
GPGerard Pasterkamp
Gerard Pasterkamp
IHImo E Hoefer
Imo E Hoefer
Targeting danger-associated molecular patterns after myocardial infarction. . ???aop.label???. doi: 10.1517/14728222.2016.1088005

20 October 2015 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
GHGerardus P. J. van Hout
Gerardus P. J. van Hout
SLSanne J. Jansen Of Lorkeers
Sanne J. Jansen Of Lorkeers
KWKimberly E. Wever
Kimberly E. Wever
ESEmily S. Sena
Emily S. Sena
LKLisanne H. J. A. Kouwenberg
Lisanne H. J. A. Kouwenberg
IHImo E. Hoefer
Imo E. Hoefer
Numerous anti-inflammatory drugs have been tested in large animal studies of myocardial infarction (MI). Despite positive results, translation of anti-inflammatory strategies into clinical practice has proved to be difficult. Critical disparities between preclinical and clinical study design that influence efficacy may partly be responsible for this translational failure. The aim of the present systematic review was to better understand which factors underlie the failure of transition towards the clinic. Meta-analysis and regression of large animal studies were performed to identify sources that influenced effect size of anti-inflammatory compounds in large animal models of MI. We included 183 studies, containing 3331 large animals. Infarct size (IS) as a ratio of the area at risk (12.7%; 95% confidence interval, CI 11.1–14.4%, P < 0.001) and IS as a ratio of the left ventricle (3.9%; 95% CI 3.1–4.7%, P < 0.001) were reduced in treatment compared with control groups. Effect size was higher when outcome was assessed early after MI (P = 0.013) and where studies included only male animals (P < 0.001). Mortality in treated animals was higher in studies that blinded the investigator during the experiment (P = 0.041) and depended on the type of drug used (P < 0.001). As expected, treatment with anti-inflammatory drugs leads to smaller infarct size in large animal MI models. Timing of outcome assessment, sex, and study quality are significantly associated with outcome and may explain part of the translational failure in clinical settings. Effect size depends on the type of drug used, enabling identification of compounds for future clinical testing.

16 June 2015 in Evidence-based Preclinical Medicine
Verified
Journal Article
Open access
PZPetrus Zwetsloot
Petrus Zwetsloot
SLS. J. Jansen Of Lorkeers
S. J. Jansen Of Lorkeers
AVA. M. D. Végh
A. M. D. Végh
GHG. P. J. Hout
G. P. J. Hout
GCG. L. Currie
G. L. Currie
JSJoost Sluijter
Joost Sluijter

14 October 2015 in Basic Research in Cardiology
Verified
Journal Article
Open access
PDF file
GHG. P. J. van Hout
G. P. J. van Hout
WSWouter van Solinge
Wouter van Solinge
CGC. M. Gijsberts
C. M. Gijsberts
MTM. P. J. Teuben
M. P. J. Teuben
PLP. H. C. Leliefeld
P. H. C. Leliefeld
IHI. E. Hoefer
I. E. Hoefer
Myocardial infarction (MI) induces an inflammatory response in which neutrophils fulfill a prominent role. Mean neutrophil volume (MNV) represents the average size of the circulating neutrophil population. Our goal was to determine the effect of MI on MNV and investigate the mechanisms behind MNV elevation. MNV of 84 MI patients was compared with the MNV of 209 stable angina patients and correlated to simultaneously measured CK levels. Fourteen pigs were subjected to temporary coronary balloon occlusion and blood was sampled at multiple time points to measure MNV. Echocardiography was performed followed by ex vivo infarct size assessment after 72 h. MNV was higher in MI patients compared to stable angina patients (602 SD26 AU vs. 580 SD20 AU, p < 0.0001) and correlated with simultaneously measured CK levels (R = 0.357, p < 0.0001). In pigs, MNV was elevated post-MI (451 SD11 AU vs. 469 SD12 AU), p < 0.0001). MNV correlated with infarct size (R = 0.705, p = 0.007) and inversely correlated with left ventricular ejection fraction (R = −0.718, p = 0.009). Cell sorting revealed an increased presence of banded neutrophils after MI, which have a higher MNV compared to mature neutrophils post-MI (495 SD14 AU vs. 478 SD11 AU, p = 0.012). MNV from coronary sinus blood was higher than MNV of neutrophils from simultaneously sampled arterial blood (463 SD7.6 AU vs. 461 SD8.6 AU, p = 0.013) post-MI. The current study shows MNV is elevated and reflects cardiac damage post-MI. MNV increases due to altered neutrophil composition and systemic neutrophil activation. MNV may be an interesting parameter for prognostic assessment in MI and provide new insights into pathological innate immune responses evoked by ischemia–reperfusion.